Artivion | CRY - Заемный капитал





Заемный капитал Изменить Дата
Abbott USD 29.64B 19.74B 2026-03
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 5.6M 100K 2025-09
Artivion USD 215.35M 2.46M 2026-03
AtriCure USD 61M 865K 2026-03
Baxter International USD 8.62B 852M 2026-03
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Boston Scientific USD 11.01B 19M 2025-12
Edwards Lifesciences USD 600M 1.7M 2026-03
Inogen USD 0 0 2022-06
Integra LifeSciences USD 1.83B 29.45M 2026-03
J&J USD 37.53B 1.91B 2026-03
Mesa Laboratories USD 104.2M 104.3M 2024-09
Orthofix International USD 221.33M 46.88M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
ResMed USD 404.17M 245K 2026-03
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 601.77M 291.73M 2026-03
Teleflex USD 2.51B 27.18M 2026-03
Terumo JPY 99.91B 13M 2026-03
Trinity Biotech USD 16.33M 98.53M 2025-12